Azithromycin Reduction to Reach Elimination of Trachoma B
Status:
WITHDRAWN
Trial end date:
2029-08-31
Target enrollment:
Participant gender:
Summary
The investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maniema, DRC. The investigators will randomize communities with up to 20% Trachomatous Inflammation - Follicular (TF) prevalence following at least 5 years of mass azithromycin distribution to discontinuation or continuation of 3 additional years of annual mass azithromycin distribution.
Phase:
PHASE4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo National Eye Institute (NEI)